Sin categoría

GP1114C MOGAD patients/caregivers in the US and the UK

A new research study is currently seeking participants in the United States/UK to learn about the experiences of people living with Myelin oligodendrocyte glycoprotein antibody-associated disease or MOGAD and those who provide unpaid care and support for them.    Participation in this study would involve a web-enabled virtual interview lasting 60 minutes. All study participants will also be asked to complete a brief homework assignment (approx. 30 minutes) to discuss during

GP0187E – MLD Patients and Caregivers in the US/UK

We are looking for individuals with metachromatic leukodystrophy (MLD) and caregivers of individuals with MLD to take part in an interview study. The aim of this study is to understand people’s experience of living with MLD and their opinions about a questionnaire.    The study will involve:   A background questionnaire which will include some questions about yourself (and the person you care for).   A video or telephone interview where a trained

GP0242E Hidradenitis suppurativa in US/EU

Global Patients, an IQVIA business, is working with Acaster Lloyd, a scientific research company, to learn the perspectives of people with a long-term skin condition. This market research is conducted on behalf of a pharmaceutical company.  You will participate in a 1-hour web assisted telephone interview so we can better understand your experiences, how your skin condition impacts your life, and your preferences for treatments for your condition. The study

GP1126C Lung cancer patients and caregivers

We are currently working on a study to learn more about the diagnosis, treatment, and quality-of-life experiences of people living with lung cancer (either patients or caregivers).   Eligible participants would take part in a longitudinal study involving 12-monthly online surveys to share their experiences. They will be compensated with up to $80 USD for their time. The survey is only available in English.  If you know someone who might be

GP1066A ATTR patients in the US

At Global Patients we currently have a new study on ATTR in the US. The study has three stages: 60 min interview for which participants will be compensated with $125 160 min ethnography over 2 weeks for which participants will be compensated $375 (8 video tasks of 5–10-minute which you will record yourself, using your phone) 60 min interview for which participants will be compensated with $125 The total amount

GP0901A Multiple Myeloma in the US

We are looking for individuals with Multiple Myeloma (MM), to participate in a 60 min or 90 min telephone interview about individuals’ experiences with these conditions. Participants will be asked to provide a confirmation of diagnosis.  

GP1006A WAIHA and ITP patients in UK

Adelphi Values, a health research organization that works with pharmaceutical companies, is conducting a study to better understand the experience of patients who have warm autoimmune hemolytic anemia (wAIHA) and immune thrombocytopenia (ITP) and how having wAIHA and ITP affects their lives. We are looking for adults who have either wAIHA or ITP to participate in a single 60-minute interview to discuss the experience of having wAIHA or ITP and

GP0287E Atopic Dermatitis and Chronic Urticaria patients in the UK

We are excited to announce a new research project focusing on individuals with different dermatological conditions. We aim to gain insights into their experiences, and to improve the way in which these impacts can be measured. The research will take the form of a 60 to 75-minute one-to-one interview, either online or in-person, and eligible participants will be compensated in appreciation of their time. If you or someone you know

GP0628D IBD in the US

IQVIA (, a healthcare research organization, is currently conducting an interview study with individuals living with inflammatory bowel disease (IBD), in particular with ulcerative colitis or Crohn’s Disease, on behalf of F. Hoffmann-La Roche Ltd. Participants will take part in a one-off 30 to 60-minute video or telephone interview (+ up to 30-minute screening call) about their experiences of taking part in or considering taking part in an IBD clinical

GP0845D Netherton Patients and Caregivers in the US

At Global Patients we are launching a new study where we want to hear from Netherton Syndrome patients and caregivers of Netherton Syndrome children in the US. The study will consist of a 60-minute telephone interview.  As a token of appreciation for their time, participants will receive a 150 USD honorarium paid upon completion of the interview. If you need more information or are interested, please do not hesitate to

GP1088A – MMN in the US

Global Patients is currently looking for adults aged 18 years or older, diagnosed with multifocal motor neuropathy (MMN) to participate in an upcoming paid interview study. The purpose of the study is to explore your experiences of having MMN and also to understand your thoughts and opinions on the content of a questionnaire that is used when carrying out research into MMN. Participants will be invited to attend a telephone

GP1130C Multiple Myeloma patients in the USA

We are currently working on a study to learn more about the experiences of people living with Multiple Myeloma via a 20-minute online survey.
Besides having the opportunity to share your voice, you will be compensated with $50 (USD) within 2 weeks of completing the survey.
If you need more information or are interested, please do not hesitate to contact us via email at
Many thanks!

GP1084C Adults and Adolescents with Crohn’s Disease

RTI International (RTI), an independent nonprofit research organization, is recruiting adults and adolescents (aged 15-17 years) to participate in a web-based interview. If you or your child have moderate to severely active CD, you or your child may be eligible to participate in an interview. Participants must be willing to provide confirmation of diagnosis from their doctor to be scheduled for an interview. An additional compensation of $50 for obtaining

GP1025C Advanced Ovarian Cancer patients in the US using PARP inhibitor

We currently have a new study in the US about Ovarian Cancer. The study will involve a 60 min interview for which participants will be compensated with $150 USD and with additional $75 USD for providing a proof of diagnosis to be eligible to participate. There is no medical treatment being provided as part of this study; it is completely non-interventional. We were wondering if you could collaborate with us

GP0951D Esclerosis Múltiple en España

We have a new study in Spain. En IQVIA, una organización de investigación clínica, estamos trabajando en un proyecto cuyo objetivo es comprender los programas de apoyo al paciente (PSP) que existen en el ámbito de la esclerosis múltiple (EM). En concreto, como alguien que vive con EM nos gustaría conocer su opinión sobre cuáles son los mayores retos en el campo de la esclerosis múltiple. Además, nos gustaría conocer

GP0331 Atopic Dermatitis in the US, UK and Canada

We currently have a study for participants in the US/UK/Canada to learn more about the experiences of patients with Atopic Dermatitis. The study consists of a 60-minute-long web-assisted interview. We appreciate the time that patients invest in these interviews, for this reason we are offering an incentive of 125USD/90GBP/150CAD as a token of appreciation for taking part. If you need more information or are interested, please do not hesitate to